Epstein-Barr viral antigens used in the diagnosis of nasopharyngeal carcinoma

Journal of Biomedical Science

Volumn 3, Issue 3, 1996, Pages 159-169

  Gan, Y Y ^a   Fones Tan, A ^a   Chan, S H ^b   Gan, L H ^a  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Antibodies; Antigens; ELISA; Epstein Barr virus; Nasopharyngeal carcinoma

Indexed keywords

EARLY ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MEMBRANE ANTIGEN; VIRUS ANTIGEN; VIRUS CAPSID ANTIGEN; VIRUS PROTEIN;

DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; HUMAN; NASOPHARYNX CARCINOMA; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEROLOGY;

HUMAN HERPESVIRUS 4; MIRIDAE;

EID: 0029761163     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/BF02253096     Document Type: Review

References (4)

1. Baylis SA, Purifoy DJM, Littler E. High level expression of the Epstein-Barr virus alkaline deoxyribonuclease using a recombinant baculovirus: Application to the diagnosis of nasopharyngeal carcinoma. Virology 181:390-394; 1991.
2. Mathew M, Cheng HM, Sam CK, Joab I, Prasad U, Cochet C. A high incidence of serum IgG antibodies to the Epstein-Barr virus replication activator protein in nasopharyngeal carcinoma. Cancer Immunol Immunother 38:68-70; 1994.
3. Van Grunsven WMJ, Spaan WJM, Middeldorp JM. Localization and diagnostic application of immunodominant domains of the BKRF3-encoded Epstein-Barr virus capsid protein. J Infect Dis 170:13-19; 1994.
4. Zeng Y, Wolf H, Tadaka K, Arrand JR, De The G. Detection of EBV specific IgA antibodies to Ea, MA and EBNA-1 recombinant proteins in NPC patients and controls. In: Ablashi DV, Faggioni A, Krueger GRF, Pagano JS, Pearson GR (eds): Epstein-Barr virus and human diseases. Humana Press, Clifton, pp 309-313.